ESC 365 - The value of biomarkers to assess stroke and bleeding risks in atrial fibrillation patients.

Open Access

The value of biomarkers to assess stroke and bleeding risks in atrial fibrillation patients.

Session: Atrial fibrillation screening and biomarkers to assess stroke and bleeding risks in atrial fibrillation patients

Topic: Arrhythmias, General

Speaker: Associate Professor Z. Hijazi (Uppsala, SE)

Sponsored by Roche Diagnostics International

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Associate Professor Ziad Hijazi

Uppsala University, Uppsala (Sweden)

4 presentations

0 follower

2 more presentations in this session

NT-proBNP: a valuable marker to screen for Atrial Fibrillation.

Speaker: Doctor K. Kemp Gudmundsdottir (Stockholm, SE)

Q&A.

Access the full session

Atrial fibrillation screening and biomarkers to assess stroke and bleeding risks in atrial fibrillation patients

Speakers: Associate Professor Z. Hijazi, Doctor K. Kemp Gudmundsdottir

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources